TREATMENT OF OSTEOPOROSIS OF AGEING WITH 1α-HYDROXYCHOLECALCIFEROL

Seven patients with osteoporosis of ageing were treated with synthetic 1α-hy- droxycholecalciferol (1α-H.C.C.) for 3-4 months. The compound was given at a daily oral dose of 2 μg together with an oral supplement of 1 g of calcium. Clinically there was a striking improvement in the patients' phy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet (British edition) 1975-12, Vol.306 (7946), p.1168-1171
Hauptverfasser: Lund, B., Kjaer, I., Friis, T., Hjorth, L., Reimann, I., Andersen, R.B., Sørensen, O.H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Seven patients with osteoporosis of ageing were treated with synthetic 1α-hy- droxycholecalciferol (1α-H.C.C.) for 3-4 months. The compound was given at a daily oral dose of 2 μg together with an oral supplement of 1 g of calcium. Clinically there was a striking improvement in the patients' physical fitness. Increased bone formation and mineralisation were seen on iliac-crest bone biopsy, and this was supported by an increased osteoblastic activity demonstrated by histochemical measurement of alkaline-phosphatase activity. Bone histology furthermore showed a reduced bone resorption, which was supported by a reduced urinary excretion of total hydroxyproline. Photon absorptiometry of the forearm accorded with the histological findings, showing a significant increase in the bone mineral content. Serum-calcium rose in all patients, one developing a severe transitory hypercalcæmia. The urinary excretion of calcium and magnesium increased significantly. The serum concentrations of 25-hydroxycholecalciferol and parathyroid hormone were not significantly affected by the treatment. It is concluded that 1α-H.C.C. is an effective tool in the treatment of senile osteoporosis.
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(75)92656-2